Guangzhou Royallee Cancer Center was officially established on November 25, 2010. It is a 3A “international-platform-based” oncology hospital under the management of the Guangdong Provincial Health Commission, featuring “whole-process management on tumor” and “high-tech treatment technology of tumor” as its mainstay. It is solely funded and constructed by the multinational group – Royallee (Thailand) International Group, which aims to bring better tumor diagnosis and treatment and medical services to cancer patients around the world. The hospital, led by the Sun Yat-sen University Cancer Center with the largest scale and strongest academic strength in China, is one of the three core projects of the “Sun Yat-sen University International Health and Medical Research Center”, as well as one of the top 500 modern industry projects in Guangdong and one of the “three major breakthroughs” projects in Guangzhou.
Guangzhou Royallee Cancer Center features multi-disciplinary diagnosis and treatment, and has established Royallee – Bojiren Medical Hepatobiliary and Pancreatic Oncology Department, Gastrointestinal Oncology Department, Palliative Medicine Center, Breast Oncology Department, Body Surface Tumor Department, Minimally Invasive Treatment Center and Health Management Center.
The hospital is also constantly exploring special services such as remote consultations with overseas hospitals, international two-way referrals, exchanges with overseas medical teams and multilingual senior medical team management. It engages in the fields of tumor prevention, treatment and rehabilitation and provides personalized, full life cycle tumor prevention and health management services for patients around the world with the most advanced tumor treatment and world-class high-quality care.
The hospital is located in the core area of China-Singapore Guangzhou Knowledge City, Huangpu District of Guangzhou City in China, with a total construction area of 77,600 square meters. There are 14 floors above the ground, of which the 1/F to 3/F are the medical technical departments, the 5/F to 14/F are the inpatient wards, two floors under the ground are used as medical rooms, restaurants and parking lots. The hospital has 12 clinical departments and 7 technical departments, 400 beds in the wards, 2 100-level laminar flow operation rooms, 4 10000-level laminar flow operating rooms and 1 compound operating room, so as to meet meet the needs of patients from all over the world. The hospital is equipped with the world’s most advanced MRI, CT and DSA, and will introduce large-scale equipment such as Da Vinci surgical robots in the second phase.
Guangzhou Royallee Cancer Center emphasizes “patient-centered” and provides patients with the best treatment through the cooperation and efforts of all medical staff and customer service staff.
The super-platform-based model breaks the traditional model of single-department. It brings together more than 100 oncologists from top hospitals at home and abroad, and from multiple departments to build a multi-disciplinary diagnosis and treatment platform for oncology elites and subdivisions to provide patients with comprehensive, accurate and scientific diagnosis and personalized treatment plans.
At the same time, the hospital will integrate international-quality medical services into the various stages of diagnosis and treatment during the patient’s stay, and provide patients with humanized, all-round and high-quality medical services by the service tenet of “patient-centered”. The meticulous whole-process service runs through the three major links of pre-hospital service, in-hospital service and post-hospital service for patients from all over the world, such as multilingual translation team support, pick-up or drop-off service at the airport or railway station for patients in need, prayer places for patients who have different religious beliefs, providing patients with the humanistic care.
The hospital attaches great importance to the quality and safety of patients’ visit. Therefore, the hospital is making a plan to obtain the Joint Commission International (JCI) certificate within 2 years, aiming to provide patients from all over the world with better and safer diagnosis and treatment services.
At the same time, the hospital is also actively communicating international insurance organizations to seek cooperation, providing more convenient service for patients’ medical treatment.
As a large-scale international tumor hospital, we are ready to serve international cancer patients. The hospital will provide services such as appointments, medical consultation, diagnosis and treatment options, domestic transportation and accommodation arrangements for patients from Southeast Asian countries such as Thailand, Malaysia, Vietnam, Indonesia and the Philippines. Patients with medical needs can contact us through official channels such as telephone, website, Facebook or official account, and we will develop a green communication channel to provide one-stop service with open treatment cost.